drospirenone

Known as: drospirenone [Chemical/Ingredient], (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, Dehydrospirorenone 
A synthetic spironolactone analogue and progestin with progestational and anti-mineralocorticoid activity. Drospirenone binds to the progesterone… (More)
National Institutes of Health

Related topics

Related topics

22 relations

Broader (2)

AndrostenesMineralocorticoid Receptor Antagonists
Cerebrovascular DisordersCoronary heart diseaseDROSPIRENONE 3 mg / ETHINYL ESTRADIOL 0.03 mg ORAL TABLET [Zarah]Drug Allergy
(More)

Narrower (1)

ZK 30595

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
OBJECTIVE To examine the risk of non-fatal idiopathic venous thromboembolism in current users of a combined oral contraceptive… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9
OBJECTIVE To assess the risk of venous thromboembolism from use of combined oral contraceptives according to progestogen type and… (More)
Is this relevant?
Review
2008
Review
2008
Impact of conjugate pneumococcal vaccines on antibiotic resistance.
Reduction of drug-resistant Streptococcus pneumoniae (DRSP) by pneumococcal conjugate vaccines (PCVs) has recently become a… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis.
PURPOSE To demonstrate the antimicrobial properties of riboflavin/UVA (365 nm) against common pathogens. METHODS One group of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation.
OBJECTIVES The study was conducted to compare risks of adverse cardiovascular and other events associated with the use of… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
OBJECTIVE The oral contraceptive ethinylestradiol 0.03 mg/drospirenone 3 mg contains a progestin component that differs from… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation.
PURPOSE This multicenter, double-blind, placebo-controlled crossover study evaluated the efficacy of a new oral contraceptive (OC… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Daily Record of Severity of Problems (DRSP): reliability and validity
The Daily Record of Severity of Problems (DRSP) form was developed to aid in the diagnosis and evaluation of DSM-IV Premenstrual… (More)
  • table 1
  • table 2
  • table 4
  • table 6
  • table 5
Is this relevant?
2003
2003
Conception and pharmacodynamic profile of drospirenone
Progesterone is more than a progestin. Beyond functions in cycle and pregnancy, progesterone binds with high affinity to the… (More)
Is this relevant?
Review
2003
Review
2003
Classification and pharmacology of progestins.
Besides the natural progestin, progesterone, there are different classes of progestins, such as retroprogesterone (i.e… (More)
Is this relevant?